A functional NPSR1 gene variant and environment shape personality and impulsive action: A longitudinal study

Journal of Psychopharmacology

Volumn 28, Issue 3, 2014, Pages 227-236

  Laas, Kariina ^a   Reif, Andreas ^b,d   Kiive, Evelyn ^a   Domschke, Katharina ^b   Lesch, Klaus Peter ^b,e   Veidebaum, Toomas ^c   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

ADHD; anxiety; arousal; impulsivity; Neuropeptide S; NPSR1; personality; stress

Indexed keywords

ASPARAGINE; ISOLEUCINE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ESTONIA; EXTRAVERSION; FAMILY RELATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HUMAN; IMPULSIVENESS; LIFE EVENT; LIFE STRESS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROSIS; NPSR1 GENE; PERSONALITY; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; TEACHER;

ADHD; ANXIETY; AROUSAL; IMPULSIVITY; NEUROPEPTIDE S; NPSR1; PERSONALITY; STRESS;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; HUMANS; IMPULSIVE BEHAVIOR; LONGITUDINAL STUDIES; MALE; PERSONALITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; YOUNG ADULT;

EID: 84895540322     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112472562     Document Type: Article

References (42)

1. Af Klinteberg B, Oreland L. Hyperactive and aggressive behaviors in childhood as related to low platelet monoamine oxidase (MAO)activity at adult age: a longitudinal study of male subjects. Pers Individ Differ. 1995 ; 19: 373-383
2. Banaschewski T, Becker K, Scherag S, et al. Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry. 2010 ; 19: 237-257
3. Chauveau F, Lange MD, Jüngling K, et al. Preventionnof stress-impaired fear extinction through neuropeptide S action in the lateral amygdala. Neuropsychopharmacology. 2012 ; 37: 1588-1599
4. Congdon E, Canli T. The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches. Behav Cogn Neurosci Rev. 2005 ; 4: 262-281
5. Cormier E. Attention deficit/hyperactivity disorder: A review and update. J Pediatr Nurs. 2008 ; 23: 345-357
6. Dannlowski U, Kugel H, Franke F, et al. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology. 2011 ; 36: 1879-1885
7. Dickman SJ. Functional and dysfunctional impulsivity: personality and cognitive correlates. J Pers Soc Psychol. 1990 ; 58: 95-102
8. Domschke K, Reif A. Behavioral genetics of affective and anxiety disorders. Curr Topics Behav Neurosci. 2012 ; 12: 463-502
9. Domschke K, Reif A, Weber H, et al. Neuropeptide S receptor gene - converging evidence for a role in panic disorder. Mol Psychiatry. 2010 ; 16: 938-948
10. Duangdao DM, Clark SD, Okamura N, et al. Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res. 2009 ; 205: 1-9
11. Ebner K, Rjabokon A, Pape H-C, et al. Increased in vivo release of neuropeptide S in the amygdala of freely moving rats after local depolarisation and emotional stress. Amino Acids. 2011 ; 41: 991-996
12. Eensoo D, Harro M, Pullmann H, et al. Association of traffic behavior with personality and platelet monoamine oxidase activity in schoolchildren. J Adolesc Health. 2007 ; 40: 311-317
13. Harro J. Inter-individual differences in neurobiology as vulnerability factors for affective disorders: Implications for psychopharmacology. Pharmacol Ther. 2010 ; 125: 402-422
14. Harro M, Eensoo D, Kiive E, et al. Platelet monoamine oxidase in healthy 9- and 15-years old children: The effect of gender, smoking and puberty. Prog Neuropsychopharmacol Biol Psychiatry. 2001 ; 25: 1497-1511
15. Harro J, Merenäkk L, Nordquist N, et al. Personality and the serotonin transporter gene: Associations in a longitudinal population-based study. Biol Psychol. 2009 ; 81: 9-13
16. Jacob CP, Romanos J, Dempfle A, et al. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci. 2007 ; 257: 309-317
17. Jüngling K, Seidenbecher T, Sosulina L, et al. Neuropeptide S-mediated control of fear expression and extinction: Role of intercalated GABAergic neurons in the amygdala. Neuron. 2008 ; 59: 298-310
18. Kallasmaa T, Allik J, Realo A, et al. The Estonian version of the NEOPI-R: an examination of universal and culture-specific aspects of the five-factor model. Eur J Pers. 2000 ; 14: 265-278
19. Kiive E, Kurrikoff T, Mäestu J, et al. Effect of α2A-adrenoceptor C-1291G genotype and Maltreatment on hyperactivity and inattention in adolescents. Prog Neuropsychopharmacol Biol Psychiatry. 2010 ; 34: 219-224
20. Klauke B, Deckert J, Zwanzger P, et al. Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions. World J Biol Psychiatry. 2012 ;:
21. Laas K, Reif A, Herterich S, et al. The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity. Psychopharmacology. 2010 ; 209: 255-261
22. Laidra K, Allik J, Harro M, et al. Agreement among adolescents, parents and teachers on adolescent personality. Assessment. 2006 ; 13: 187-196
23. Lesch K-P, Timmesfeld N, Renner TJ, et al. Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm. 2008 ; 115: 1573-1585
24. Lukas M, Neumann ID. Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: Social versus non-social effects. Neuropharmacology. 2012 ; 62: 398-405
25. Monroe SM. Modern approaches to conceptualizing and measuring human life stress. Annu Rev Clin Psychol. 2008 ; 4: 33-52
26. Mõttus R, Pullmann H, Allik J. Towards more readable Big Five personality inventories. Eur J Psychol Assess. 2006 ; 22: 149-157
27. Neale BM, Lasky-Su J, Anney R, et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008 ; 147B: 1337-1344
28. Okamura N, Hashimoto K, Iyo M, et al. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007 ; 31: 1444-1448
29. Paaver M, Kurrikoff T, Nordquist N, et al. The effect of 5-HTT gene promoter polymorphism on impulsivity depends on family relations in girls. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 1263-1268
30. Paavonen EJ, Räikkönen K, Lahti J, et al. Short sleep duration and behavioral symptoms of attention-deficit/hyperactivity disorder in healthy 7- to 8-year-old children. Pediatrics. 2009 ; 123: 857-864
31. Raczka KA, Gartmann N, Mechias M-L, et al. A neuropeptide S receptor variant associated with overinterpretation of fear reactions: A potential neurogenetic basis for catastrophizing. Mol Psychiatry. 2010 ; 15 1045: 1067-1074
32. Reif A, Kiive E, Kurrikoff T, et al. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology. 2011 ; 214: 239-248
33. Reinscheid RK. Neuropeptide S: Anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ. 2008 ; 46: 145-158
34. Reinscheid RK, Xu YL. Neuropeptide S as a novel arousal promoting peptide transmitter. FEBS J. 2005 ; 272: 5689-5693
35. Reinscheid RK, Xu YL, Okamura N, et al. Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther. 2005 ; 315: 1338-1345
36. Rizzi A, Vergura R, Marzola G, et al. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol. 2008 ; 154: 471-479
37. Smith KL, Patterson M, Dhillo WS, et al. Neuropeptide S stimulates the hypothalamopituitary-adrenal axis and inhibits food intake. Endocrinology. 2006 ; 147: 3510-3518
38. Tomson K, Merenäkk L, Loit H-M, et al. The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Prog Neuropsychopharmacol Biol Psychiatry. 2011 ; 35: 1857-1862
39. Wegener G, Finger BC, Elfving B, et al. Neuropeptides alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: A genetic animal model of depression. Int J Neuropsychopharmacol. 2012 ; 15: 375-387
40. Xu YL, Gall CM, Jackson VR, et al. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expression neurons in the rat brain. J Comp Neurol. 2007 ; 500: 84-102
41. Xu YL, Reinscheid RK, Huitron-Resendiz S, et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron. 2004 ; 43: 487-497
42. Zhao P, Shao YF, Zhang M, et al. Neuropeptide S promotes wakefulness through activation of the posterior hypothalamic histaminergic and orexinergic neurons. Neuroscience. 2012 ; 201: 218-226